The Psychedelics as Medicine Report: Fourth Edition
On Tuesday, 29 November, PSYCH released the fourth edition of The Psychedelics as Medicine Report.
The report, expanded to include data on adult-use frameworks, contains market valuations and contributions from business leaders, researchers and regulators, empowering investors to make informed decisions.
It revealed the industry is currently worth US$650 million, and is expected to exceed US$3 billion by 2026. The next three years will be pivotal in the adoption of psychedelic healthcare, with MDMA and psilocybin-assisted therapies expected to be regulated on both sides of the Atlantic.
To navigate the rapidly changing landscape, The Psychedelics as Medicine Report provides a holistic overview of the interventions poised for market approval, and a balanced perspective of the related socioeconomic opportunities.READ MORE